Caroline Xie

Parabilis Medicines™ is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by unlocking biologically important targets long considered undruggable. The company has pioneered a new class of alpha-helical peptides – Helicons™ – capable of modulating intracellular proteins that have historically been beyond the reach of conventional medicines. The company’s lead investigational medicine, zolucatetide, is the first and only direct inhibitor of the β-catenin:TCF interaction, a central node in the Wnt/β-catenin pathway that has eluded drug developers for decades. Zolucatetide is being evaluated in the clinic across multiple Wnt/β-catenin-driven diseases, including desmoid tumors, familial adenomatous polyposis (FAP) and a range of other solid tumor indications. Beyond zolucatetide, Parabilis is advancing additional Helicon-based programs focused on other challenging targets where we believe our medicines could have life-altering impact.

Launched during the Mayo Clinic Platform Accelerate program, backed by Sequoia and Google, and an official Content Partner of the New England Journal of Medicine and The Journal of the American Medical Association OpenEvidence is the world’s leading medical information platform.

Strand was founded by biological engineers working together at the Massachusetts Institute of Technology (MIT). Building on the idea of creating smart therapies capable of making sophisticated decisions, they sought to apply this concept to the emerging field of mRNA therapeutics. This area was previously untapped by traditional synthetic biology, leading us to build our very own mRNA programming language, creating the world’s first platform for mRNA smart therapies. Strand’s mRNA programming technology promises to make mRNA therapies safer and more effective by programming the location, timing, and intensity of therapeutic protein expression inside a patient’s body via mRNA-encoded logic circuits. These circuits have the ability to implement cell-type specific expressions by sensing and classifying the unique mRNA expression signatures of cells and control the dosage of protein expression through responses to exogenously administered small molecules.

**We have been made aware of individuals falsely posing as recruiters from Assured Insurance Technologies Inc. Please note that we only contact candidates from official @assured.claims email addresses and all interviews are conducted through verified company channels. If you are unsure whether a message is legitimate, please contact us directly at recruiting-ops@assured.claims before sharing any personal information** Assured is the the AI engine powering the next era of claims, transforming how carriers ingest, service, and process claims.

Our mission at Causaly is to redefine the boundaries of human discovery by harnessing transformative AI technologies. Founded in 2018, Causaly’s unique AI platform is a powerful catalyst for the modern Life Science research organization, reshaping how data is found, analyzed and applied in critical decision-making processes in drug discovery and development. Supporting a broad range of complex knowledge workflows, our platform accelerates the journey from bench research and laboratory insights to the launch of life-changing therapies.

Incubated at Providence, one of the nation’s largest health systems, DexCare is a data-driven intelligence company focused on making access to healthcare better for everyone. DexCare’s core offering is a software platform, provided exclusively to health systems, that orchestrates digital demand and health system capacity across all lines of care. The platform attracts high-value, commercially-insured consumers by providing a highly discoverable, fully-digitized and unified experience while amplifying health systems’ existing EMR, caregiver and brand investments. The uniqueness of DexCare lies within its intelligent navigation and load balancing across providers, settings, modalities and service lines. DexCare’s data-driven engine allocates, flexes and optimizes resources to best meet both consumer demand and health system business goals. DexCare powers the digital engine of leading health systems across the U.S., including Kaiser Permanente, Houston Methodist, Mass General Brigham and others. DexCare-powered digital experiences attract 30% more new patients, 85% of whom are commercially insured, capture 8x downstream revenue, generate over 20% per patient encounter in cost savings, and deliver net promoter satisfaction greater than 90%.

Apprentice’s Tempo Manufacturing Cloud is the first AI-powered cloud platform for batch-based manufacturing. Tempo connects your teams, systems, sites, and external partners across one cloud-based platform to provide seamless processing through every layer of your manufacturing ecosystem. By combining historically distributed systems — Manufacturing Execution System (MES), Distributed Control System (DCS), Laboratory Execution System (LES), eLogs, Work Instructions, Tempo optimizes end-to-end manufacturing processes. AI is embedded in every step of the process, driving innovation from design to creation, through to simulation and execution, delivering the power of the next generation of manufacturing technology, today. To learn more about Apprentice, visit www.apprentice.io

Notable is the AI platform for healthcare operations. Deployed at over 10,000 sites of care, Notable automates over a million repetitive workflows every day across Registration and Intake, Scheduling and Referrals, Assistant, Authorizations, Care Gap Closure, and HCC Chart Review. The result: personalized, streamlined care for patients, the elimination of burdensome manual work for caregivers, and improved financial health for healthcare providers. Based in San Mateo, Calif., Notable is backed by leading investors, including ICONIQ Growth, Greylock Partners, F-Prime, Oak HC/FT, Maverick Ventures, and 8VC. Find out why healthcare providers of all sizes, including Intermountain Health, Medical University of South Carolina, North Kansas City Hospital, and more have joined Notable on its mission to simplify and optimize healthcare for humanity at: notablehealth.com and follow us on Twitter @notablehealth.

At Twin, we combine advanced medical science with digital twin technology to help people reverse, improve, and prevent chronic metabolic diseases like type 2 diabetes, pre-diabetes, and heart disease. We do it by helping each Twin member improve their metabolic fitness. Our truly precise and personalized approach makes us a service like no other. Our passion and dedication make us a team like no other. The pillars of the Twin Service are our Whole Body Digital Twin™ and dedicated care team; together, they provide each member with individualized attention throughout their healthy journey. Each member’s Digital Twin utilizes wearable health technology to build a dynamic digitalization of their unique metabolism. Our members receive daily guidance from their Twin, and as their metabolism heals, their Twin continues to learn — allowing them to introduce new foods and activities. These daily insights help our members sustain a healthy life, personalized to them. This high-tech precision is supported by a dedicated care team of doctors, nurses, dietitians, and health coaches who provide support, education, and guidance for members throughout their journey. Each person who works on the Twin team shares a mission-driven mentality and interest in helping people. As our team grows, we hold ourselves accountable to a work-life balance that puts us in the best position to help our members.

At Devoted Health, we’re on a mission to dramatically improve the health and well-being of older Americans by caring for every person like family. Founded in 2017, weve grown fast and now serve members all across the United States. Weve gathered smart, diverse, and big-hearted people to create a new kind of all-in-one healthcare company — one that combines compassion, health insurance, clinical care, service, and technology -- to deliver a complete and integrated healthcare solution that delivers high quality care that everyone would want for someone they love. Were only just getting started! So join us on this mission: https://devoted.com/careers/

Reify Health is paving the way to faster, predictable, and more accessible clinical trials. Through its business entities, OneStudyTeam and Care Access, the company provides best-in-class trial optimization software and transformative clinical trial infrastructure that delivers research directly to more healthcare providers, communities, and patients wherever they are. Through partnerships with top biopharma companies, thousands of research clinics worldwide, and leading healthcare & community organizations, Reify Health is helping bring new medicines to patients faster, one trial at a time. Learn more at: www.reifyhealth.com

Nayya is on a mission to connect peoples most important information, so they can thrive in their health and wealth. Our intelligent and intuitive platform empowers individuals to make confident decisions, improve outcomes, and unlock the full potential of their futures. Through advanced technology, centralized data, and seamless automation, we transform outdated benefits experiences into personalized, valuable interactions that create clarity and impact for millions of employees, thousands of employers, and market leading partners alike. With the strength of our team, our partners, and our purpose, we’re building the ultimate engine to power human thriving. Explore what’s next at nayya.com.

Founded in 2013 by Military Veterans, Unite Us is the nation’s premier technology provider for integrating health and community-based care. Our proven product suite is used to proactively identify needs using advanced analytics, coordinate services between sectors in real-time, streamline referral and case management, and facilitate eligibility assessments and reimbursements across government, healthcare, health plans, and community organizations. The first of its kind, our closed-loop referral system prioritizes privacy and dignity and has integrated data and analytics tools used to measure impact, optimize programs, and shape policy. We host the nation’s largest outcomes-focused network built on accountability and trust, delivering more than 1.7M community-based health and economic services dedicated to improving whole-person health. We are your partner for integrating health and human services.

Improving lives through the largest, most actionable Healthcare Map™. At Komodo Health, we partner with our customers to improve patient care and reduce disease burden through data-driven insights. The Komodo Health Platform delivers patient-level insights by dynamically analyzing the broadest array of data across patients, practitioners, and health systems. We put patients at the center of clinical innovation. Healthcare today is all about delivering value — improving patient outcomes while reducing healthcare costs by helping our customers put life-saving therapies in the hands of people that need them the most. The Komodo Health software platform provides access to a broader array of healthcare stakeholders in over fifty therapeutic areas. Our comprehensive Healthcare Map™ helps: + Life Sciences extend the reach of innovative therapies + Patient Advocacy align investments toward the right patients and practitioners + Healthcare Practitioners address unmet medical needs in their communities + Payers increase care quality while reducing cost Let’s work together to reduce the burden of disease. Please learn more by visiting us at www.komodohealth.com.

We believe everyone deserves affordable and convenient healthcare. Our mission is to build better ways for people to find the right care at the best price. Our technology gives all Americans — regardless of income or insurance status — the knowledge, choice, and care they need to stay healthy. GoodRx supports all Americans with their healthcare challenges. Since 2011, we’ve helped Americans save over $35 billion on prescriptions via savings cards, our website, and the GoodRx app, which is one of the most downloaded medical apps on both the Google Play and Apple App Store. We’re a customer-first company. That means making sure all our products and features are built around you. This approach guides how we operate, make decisions across our businesses, and work on new ideas for our customers. In 2021, an estimated 46 million U.S. adults were not able to afford needed care. We’re working to narrow this access gap. We have saved Americans over $30 billion on their medications.

Parabilis Medicines™ is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by unlocking biologically important targets long considered undruggable. The company has pioneered a new class of alpha-helical peptides – Helicons™ – capable of modulating intracellular proteins that have historically been beyond the reach of conventional medicines. The company’s lead investigational medicine, zolucatetide, is the first and only direct inhibitor of the β-catenin:TCF interaction, a central node in the Wnt/β-catenin pathway that has eluded drug developers for decades. Zolucatetide is being evaluated in the clinic across multiple Wnt/β-catenin-driven diseases, including desmoid tumors, familial adenomatous polyposis (FAP) and a range of other solid tumor indications. Beyond zolucatetide, Parabilis is advancing additional Helicon-based programs focused on other challenging targets where we believe our medicines could have life-altering impact.

Launched during the Mayo Clinic Platform Accelerate program, backed by Sequoia and Google, and an official Content Partner of the New England Journal of Medicine and The Journal of the American Medical Association OpenEvidence is the world’s leading medical information platform.

Strand was founded by biological engineers working together at the Massachusetts Institute of Technology (MIT). Building on the idea of creating smart therapies capable of making sophisticated decisions, they sought to apply this concept to the emerging field of mRNA therapeutics. This area was previously untapped by traditional synthetic biology, leading us to build our very own mRNA programming language, creating the world’s first platform for mRNA smart therapies. Strand’s mRNA programming technology promises to make mRNA therapies safer and more effective by programming the location, timing, and intensity of therapeutic protein expression inside a patient’s body via mRNA-encoded logic circuits. These circuits have the ability to implement cell-type specific expressions by sensing and classifying the unique mRNA expression signatures of cells and control the dosage of protein expression through responses to exogenously administered small molecules.

**We have been made aware of individuals falsely posing as recruiters from Assured Insurance Technologies Inc. Please note that we only contact candidates from official @assured.claims email addresses and all interviews are conducted through verified company channels. If you are unsure whether a message is legitimate, please contact us directly at recruiting-ops@assured.claims before sharing any personal information** Assured is the the AI engine powering the next era of claims, transforming how carriers ingest, service, and process claims.

Our mission at Causaly is to redefine the boundaries of human discovery by harnessing transformative AI technologies. Founded in 2018, Causaly’s unique AI platform is a powerful catalyst for the modern Life Science research organization, reshaping how data is found, analyzed and applied in critical decision-making processes in drug discovery and development. Supporting a broad range of complex knowledge workflows, our platform accelerates the journey from bench research and laboratory insights to the launch of life-changing therapies.